LF Ruffer European I Acc
Pricing frequency
Weekly
Dealing cut off time
08:45
Type
OEIC
Yield
1.10%
NAV
5.39p
Income frequency
Semi-annually
Ongoing charge
1.07%
Latest actual NAV date
Invalid date
ISIN
GB00B03J9Q21
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/06/2023 | % of assets |
|---|---|
| Ringmetall SE | 0.44 |
| International Petroleum Corp | 0.08 |
| Let's Gowex SA | 0.00 |
| 4d pharma PLC | 0.00 |
| 4d pharma PLC ADR | 0.00 |
| 4d Pharma Wts 10/03/2025 | 0.00 |
Investment objective
To seek to achieve capital growth over the longer term (at least seven years), after all costs and charges have been taken. Capital invested is at risk and there is no guarantee that the objective will be achieved over any time period. To invest both directly and indirectly at least 70% of its total assets by value in equity or equity related securities of European (including United Kingdom) companies. These are companies that are listed or incorporated or domiciled in Europe, including the United Kingdom. As part of the equity exposure, the Sub-fund may invest in Investment Trusts.